Product Code: GVR-4-68040-179-5
Animal Sedative Market Summary
The global animal sedative market size was estimated at USD 227.0 million in 2024 and is projected to reach USD 381.0 million by 2033, growing at a CAGR of 6.04% from 2025 to 2033. The market is progressing, driven by growth in the livestock industry and meat production, expansion of veterinary surgical and diagnostic procedures, and advances in veterinary pharmacology and drug development.
The livestock sector represents another strong market growth driver. Along with increasing global demand for meat, dairy, and poultry products, sedatives are widely used to manage stress, facilitate transportation, and improve handling safety in large animals like cattle, horses, and pigs.
Sedation reduces stress-related weight loss, improves reproduction management, and enhances overall productivity in livestock operations. Additionally, government initiatives for animal welfare and regulations around humane handling are encouraging the responsible use of sedatives. As livestock farming intensifies to meet global food needs, the demand for effective and safe sedative solutions is expected to rise steadily.
Global Animal Sedative Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the animal sedative market report based on application, animal, route of administration, drug class, end use, and region:
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Surgical
- Diagnostic
- Euthanasia
- Others
- Animal Outlook (Revenue, USD Million, 2021 - 2033)
- Dogs
- Cats
- Horses
- Others
- Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
- Parenteral
- Oral
- Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
- Phenothiazines
- Benzodiazepines
- Alpha-2 Adrenergic Receptor Agonists
- Butyrophenones
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Veterinary Hospitals & Clinics
- Specialty Centers
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- India
- China
- South Korea
- Australia
- Thailand
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Animal Sedative Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Pet Ownership
- 3.2.1.2. Rising Prevalence Of Chronic Diseases In Animals
- 3.2.1.3. Increasing Animal Health Expenditure
- 3.2.1.4. Rising Surgical Procedures
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Stringent regulations
- 3.2.2.2. Side effects associated with sedatives
- 3.2.2.3. Lack of Skilled Professionals
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Animal Sedative Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Pricing Analysis
- 3.3.5. Estimated Animal Population, by key countries & key species, 2024
Chapter 4. Animal Sedative Market: Application Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Animal Sedative Market: Application Movement Analysis
- 4.3. Animal Sedative Market Size & Trend Analysis, by application, 2021 to 2033 (USD Million)
- 4.4. Surgical
- 4.4.1. Surgical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Diagnostic
- 4.5.1. Diagnostic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Euthanasia
- 4.6.1. Euthanasia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Others
- 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Animal Sedative Market: Animal Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Animal Sedative Market: Animal Movement Analysis
- 5.3. Animal Sedative Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
- 5.4. Dogs
- 5.4.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Cats
- 5.5.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Horses
- 5.6.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Animal Sedative Market: Route of Administration Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Animal Sedative Market: By Route of Administration Movement Analysis
- 6.3. Animal Sedative Market Size & Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
- 6.3.1. Parenteral
- 6.3.1.1. Parenteral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.2. Oral
- 6.3.2.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Animal Sedative Market: Drug Class Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Animal Sedative Market: Drug Class Movement Analysis
- 7.3. Animal Sedative Market Size & Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
- 7.4. Phenothiazines
- 7.4.1. Phenothiazines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Benzodiazepines
- 7.5.1. Benzodiazepines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Alpha-2 Adrenergic Receptor Agonists
- 7.6.1. Alpha-2 Adrenergic Receptor Agonists Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Butyrophenones
- 7.7.1. Butyrophenones Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Others
- 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Animal Sedative Market: End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Animal Sedative Market: By End Use Movement Analysis
- 8.3. Animal Sedative Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 8.3.1. Veterinary Hospitals & Clinics
- 8.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. Specialty Centres
- 8.3.2.1. Specialty Centres Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Others
- 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Animal Sedative Market: Regional Estimates & Trend Analysis
- 9.1. Regional Dashboard
- 9.2. Animal Sedative Market Share, By Region, 2024 & 2033, USD Million
- 9.3. Regional Outlook
- 9.4. North America
- 9.4.1. North America Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.4.2. U.S.
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Competitive Scenario
- 9.4.2.3. U.S. Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Canada
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Competitive Scenario
- 9.4.3.3. Canada Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. Mexico
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Competitive Scenario
- 9.4.4.3. Mexico Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5. Europe
- 9.5.1. Europe Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. UK
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. UK Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. Germany
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Germany Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. France
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Competitive Scenario
- 9.5.4.3. France Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Italy
- 9.5.5.1. Key Country Dynamics
- 9.5.5.2. Competitive Scenario
- 9.5.5.3. Italy Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.6. Spain
- 9.5.6.1. Key Country Dynamics
- 9.5.6.2. Competitive Scenario
- 9.5.6.3. Spain Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. Denmark
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Competitive Scenario
- 9.5.7.3. Denmark Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.8. Sweden
- 9.5.8.1. Key Country Dynamics
- 9.5.8.2. Competitive Scenario
- 9.5.8.3. Sweden Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.9. Norway
- 9.5.9.1. Key Country Dynamics
- 9.5.9.2. Competitive Scenario
- 9.5.9.3. Norway Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6. Asia Pacific
- 9.6.1. Asia Pacific Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Japan
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Japan Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. China
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. China Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.4. India
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Competitive Scenario
- 9.6.4.3. India Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.5. Australia
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Competitive Scenario
- 9.6.5.3. Australia Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.6. South Korea
- 9.6.6.1. Key Country Dynamics
- 9.6.6.2. Competitive Scenario
- 9.6.6.3. South Korea Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.7. Thailand
- 9.6.7.1. Key Country Dynamics
- 9.6.7.2. Competitive Scenario
- 9.6.7.3. Thailand Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.7. Latin America
- 9.7.1. Latin America Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. Brazil
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Competitive Scenario
- 9.7.2.3. Brazil Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Argentina
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Competitive Scenario
- 9.7.3.3. Argentina Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8. Middle East & Africa
- 9.8.1. Middle East & Africa Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.2. South Africa
- 9.8.2.1. Key Country Dynamics
- 9.8.2.2. Competitive Scenario
- 9.8.2.3. South Africa Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.3. Saudi Arabia
- 9.8.3.1. Key Country Dynamics
- 9.8.3.2. Competitive Scenario
- 9.8.3.3. Saudi Arabia Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.4. UAE
- 9.8.4.1. Key Country Dynamics
- 9.8.4.2. Competitive Scenario
- 9.8.4.3. UAE Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.5. Kuwait
- 9.8.5.1. Key Country Dynamics
- 9.8.5.2. Competitive Scenario
- 9.8.5.3. Kuwait Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.6. Qatar
- 9.8.6.1. Key Country Dynamics
- 9.8.6.2. Competitive Scenario
- 9.8.6.3. Qatar Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.7. Oman
- 9.8.7.1. Key Country Dynamics
- 9.8.7.2. Competitive Scenario
- 9.8.7.3. Oman Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.2. Company Market Position Analysis/ Heat Map Analysis
- 10.3. Company Profiles
- 10.3.1. Zoetis Services LLC
- 10.3.1.1. Participant's Overview
- 10.3.1.2. Financial Performance
- 10.3.1.3. Product Benchmarking
- 10.3.1.4. Strategic Initiatives
- 10.3.2. Virbac.
- 10.3.2.1. Participant's Overview
- 10.3.2.2. Financial Performance
- 10.3.2.3. Product Benchmarking
- 10.3.2.4. Strategic Initiatives
- 10.3.3. Ouro Fino Saude Animal Group
- 10.3.3.1. Participant's Overview
- 10.3.3.2. Financial Performance
- 10.3.3.3. Product Benchmarking
- 10.3.3.4. Strategic Initiatives
- 10.3.4. Dechra
- 10.3.4.1. Participant's Overview
- 10.3.4.2. Financial Performance
- 10.3.4.3. Product Benchmarking
- 10.3.4.4. Strategic Initiatives
- 10.3.5. Merck & Co., Inc.
- 10.3.5.1. Participant's Overview
- 10.3.5.2. Financial Performance
- 10.3.5.3. Product Benchmarking
- 10.3.5.4. Strategic Initiatives
- 10.3.6. Bimeda Inc.
- 10.3.6.1. Participant's Overview
- 10.3.6.2. Financial Performance
- 10.3.6.3. Product Benchmarking
- 10.3.6.4. Strategic Initiatives
- 10.3.7. vetcar e.fi.
- 10.3.7.1. Participant's Overview
- 10.3.7.2. Financial Performance
- 10.3.7.3. Product Benchmarking
- 10.3.7.4. Strategic Initiatives
- 10.3.8. Chanelle Pharma
- 10.3.8.1. Participant's Overview
- 10.3.8.2. Financial Performance
- 10.3.8.3. Product Benchmarking
- 10.3.8.4. Strategic Initiatives
- 10.3.9. Randlab Australia Pty Ltd.
- 10.3.9.1. Participant's Overview
- 10.3.9.2. Financial Performance
- 10.3.9.3. Product Benchmarking
- 10.3.9.4. Strategic Initiatives
- 10.3.10. Troy Laboratories Pty Ltd
- 10.3.10.1. Participant's Overview
- 10.3.10.2. Financial Performance
- 10.3.10.3. Product Benchmarking
- 10.3.10.4. Strategic Initiatives
- 10.4. Strategy Mapping
- 10.4.1. Mergers & Acquisitions
- 10.4.2. Partnerships & Collaborations
- 10.4.3. Product/ Service launch
- 10.4.4. Others